Glycated albumin levels, as an estimator of prestroke glycaemic variability, is a good predictor of symptomatic haemorrhagic transformation in patients with intravenous thrombolysis (IVT), a recent study has found.
For individuals with class I obesity, a very low-calorie ketogenic diet (VLCKD) with omega-3 supplementation results in fat mass reduction while preserving fat-free mass (FFM), as shown in a study. Furthermore, there are improvements seen in satiety hormones, such as higher ghrelin and lower leptin, and in the metabolic profiles.
Obstructive sleep apnoea (OSA) treatment with continuous positive airway pressure (CPAP) has the potential to resolve metabolic syndrome in adult patients, according to data from the TREATOSA-MS study.
Mild autonomous cortisol secretion (MACS), a cardiometabolic risk condition, mainly affects women with benign adrenal tumour and requires regular assessment for hypertension and type 2 diabetes (T2D), reveals a study.
Treatment with percutaneous ethanol injection (PEI) appears to produce marked reductions in the volume of benign cystic thyroid nodules, with the reduction evident at 6 months post-treatment and stable over time, according to the results of a meta-analysis.
Low platelet counts, along with low levels of interleukin (IL)-15 and granulocyte-macrophage colony-stimulating factor (GM-CSF), seem to be good prognostic indicators of metastatic disease in patients with pancreatic ductal adenocarcinoma (PDAC), a recent study has found.
The risk of pancreatic ductal adenocarcinoma (PDAC) appears to be higher among individuals with diabetes than in the general population, as well as in men than women, according to a study. Prediction models built around this finding demonstrate moderate accuracy for pinpointing men at high risk of PDAC, in whom surveillance may be required.
The visceral fat area (VFA) index and visceral fat density (VFD) are independently related to the prevalence of nonalcoholic fatty liver disease (NAFLD), according to a study. However, the VFD appears to have a stronger link to the incidence of NAFLD than the VFA index.
Supplementation with vitamin D, particularly at the lower dosage of 600 IU/day, appears to confer positive effects on high-density lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol, with significant changes persisting after the supplementation period, a study has shown.